Impax Asset Management Group plc reduced its stake in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 38.1% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,035,969 shares of the medical research company’s stock after selling 638,988 shares during the period. Agilent Technologies accounts for 1.4% of Impax Asset Management Group plc’s portfolio, making the stock its 20th biggest holding. Impax Asset Management Group plc owned 0.37% of Agilent Technologies worth $178,508,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds also recently made changes to their positions in the company. Bank of New York Mellon Corp raised its stake in Agilent Technologies by 87.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock worth $695,227,000 after acquiring an additional 2,440,360 shares during the period. Legal & General Group Plc purchased a new position in Agilent Technologies during the second quarter valued at approximately $260,101,000. Bank of America Corp DE bought a new position in shares of Agilent Technologies in the second quarter worth approximately $213,269,000. Man Group plc bought a new position in shares of Agilent Technologies in the second quarter worth approximately $179,257,000. Finally, Primecap Management Co. CA bought a new position in shares of Agilent Technologies in the second quarter worth approximately $176,318,000.
Insider Buying and Selling
In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of the business’s stock in a transaction on Friday, September 4th. The shares were sold at an average price of $151.38, for a total value of $95,974.92. Following the sale, the director owned 4,924 shares in the company, valued at $745,395.12. The trade was a 11.41% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Agilent Technologies Trading Down 0.4%
Shares of A opened at $172.29 on Wednesday. The firm has a market cap of $48.58 billion, a P/E ratio of 28.53, a price-to-earnings-growth ratio of 2.54 and a beta of 1.24. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $182.99. The company has a 50 day simple moving average of $169.37 and a two-hundred day simple moving average of $138.58.
Agilent Technologies (NYSE:A – Get Free Report) last released its earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The firm had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.84 billion. During the same quarter in the previous year, the firm earned $1.37 earnings per share. The company’s quarterly revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, equities analysts expect that Agilent Technologies, Inc. will post 6.20 earnings per share for the current fiscal year.
Agilent Technologies Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Wednesday, October 28th. Shareholders of record on Tuesday, October 6th were issued a $0.2550 dividend. This represents a $1.02 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date was Tuesday, October 6th. Agilent Technologies’s payout ratio is currently 20.08%.
Analyst Upgrades and Downgrades
A has been the topic of several recent analyst reports. Evercore raised their price objective on shares of Agilent Technologies from $148.00 to $178.00 and gave the company an “outperform” rating in a research report on Wednesday, October 7th. Stifel Nicolaus lifted their target price on shares of Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a research note on Thursday, August 27th. TD Cowen upped their target price on shares of Agilent Technologies from $180.00 to $196.00 and gave the stock a “buy” rating in a report on Tuesday, October 13th. Wells Fargo & Company increased their price target on Agilent Technologies from $160.00 to $180.00 and gave the stock an “overweight” rating in a research note on Friday, August 28th. Finally, Robert W. Baird increased their price target on Agilent Technologies from $180.00 to $195.00 and gave the stock an “outperform” rating in a research note on Thursday, October 8th. Eighteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, Agilent Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $181.45.
View Our Latest Stock Report on Agilent Technologies
Agilent Technologies Company Profile
Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research. The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.
See Also
- Five stocks we like better than Agilent Technologies
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
